Antonio Scilimati graduated cum laude in Chemistry at the University of Bari (Bari, Italy). PhD at the University of Wisconsin (Madison, USA). Four years as a Qualified Person at MerckSerono plant producing recombinant drugs. Currently, he is an Associate Professor of Medicinal Chemistry at the University of Bari. His scientific interest focus the pharmaceutical sciences, targeting the cyclooxygenase (COX)-1 as a novel theranostic biomarker in oncology and neuroinflammation.
